Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med.

Investigación y Educación

WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Alvarez-Moreno CA, Bravo J, Saavedra C, Chacon J, Zuluaga I, et al, 2/12/2020.

BACKGROUND
World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs — remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a — in patients hospitalized with coronavirus disease 2019 (Covid-19). 

CONCLUSIONS
These remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay. (Funded by the World Health Organization; ISRCTN Registry number, ISRCTN83971151; ClinicalTrials.gov number, NCT04315948.)

Read full article

Artículos que te pueden interesar

Enfermedades infecciosas

Consensus recommendations based on evidence for abdominal sepsis in the pediatric and adult population of colombia. Infectio,

Julio 30, 2022

Leer más

Enfermedades infecciosas

Candida auris: A Latent Threat to Critically Ill Patients with Coronavirus Disease 2019. Clin Infect Dis.

Noviembre 2, 2021

Leer más

Enfermedades infecciosas

Knowledge, attitudes, and behavior regarding antibiotics, antibiotic use, and antibiotic resistance in students and health care professionals of the district of Barranquilla (Colombia): A cross-sectional survey. Heliyon.

Noviembre 1, 2022

Leer más